These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37039367)

  • 1. Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.
    Dougherty EJ; Chen LY; Awad KS; Ferreyra GA; Demirkale CY; Keshavarz A; Gairhe S; Johnston KA; Hicks ME; Sandler AB; Curran CS; Krack JM; Ding Y; Suffredini AF; Solomon MA; Elinoff JM; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L783-L798. PubMed ID: 37039367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension.
    Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension.
    Gairhe S; Awad KS; Dougherty EJ; Ferreyra GA; Wang S; Yu ZX; Takeda K; Demirkale CY; Torabi-Parizi P; Austin ED; Elinoff JM; Danner RL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
    Szulcek R; Sanchez-Duffhues G; Rol N; Pan X; Tsonaka R; Dickhoff C; Yung LM; Manz XD; Kurakula K; Kiełbasa SM; Mei H; Timens W; Yu PB; Bogaard HJ; Goumans MJ
    Angiogenesis; 2020 Nov; 23(4):699-714. PubMed ID: 32813135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α.
    Wang S; Awad KS; Chen LY; Siddique MAH; Ferreyra GA; Wang CL; Joseph T; Yu ZX; Takeda K; Demirkale CY; Zhao YY; Elinoff JM; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2024 Oct; 327(4):L503-L519. PubMed ID: 39159362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma Suppressor of Tumorigenicity 1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.
    Wen B; Peng R; Kong P; Li Z; Liu Y; Ouyang W; Xie Y; Hu X; Wang Q; Pan X
    Am J Respir Cell Mol Biol; 2022 Dec; 67(6):666-679. PubMed ID: 36169661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells.
    Cheng SL; Shao JS; Behrmann A; Krchma K; Towler DA
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1679-89. PubMed ID: 23685555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
    Le Vely B; Phan C; Berrebeh N; Thuillet R; Ottaviani M; Chelgham MK; Chaumais MC; Amazit L; Humbert M; Huertas A; Guignabert C; Tu L
    Am J Respir Cell Mol Biol; 2022 Aug; 67(2):215-226. PubMed ID: 35550008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
    Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of DLL4/NOTCH1 Causes Dysregulated PPARγ/AKT Signaling in Pulmonary Arterial Hypertension.
    Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
    bioRxiv; 2024 Feb; ():. PubMed ID: 38903104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
    Sun X; Sun Y; Jiang P; Qi G; Chen X
    Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumol suppresses endothelial-to-mesenchymal transition via inhibiting the AKT/GSK3β signaling pathway and alleviates pulmonary arterial hypertension in rats.
    Nie X; Wu Z; Shang J; Zhu L; Liu Y; Qi Y
    Eur J Pharmacol; 2023 Mar; 943():175546. PubMed ID: 36706802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation.
    Sahoo S; Li Y; de Jesus D; Sembrat J; Rojas MM; Goncharova E; Cifuentes-Pagano E; Straub AC; Pagano PJ
    Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H542-H557. PubMed ID: 34296965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
    Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1.
    Aranguren XL; Beerens M; Coppiello G; Wiese C; Vandersmissen I; Lo Nigro A; Verfaillie CM; Gessler M; Luttun A
    J Cell Sci; 2013 Mar; 126(Pt 5):1164-75. PubMed ID: 23345397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway.
    Wang Q; Tian J; Li X; Liu X; Zheng T; Zhao Y; Li X; Zhong H; Liu D; Zhang W; Zhang M; Li M; Zhang M
    Hypertension; 2022 May; 79(5):960-973. PubMed ID: 35249365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Nox1 oxidase assembly in human pulmonary arterial hypertension; driver of Gremlin1-mediated proliferation.
    Ghouleh IA; Sahoo S; Meijles DN; Amaral JH; de Jesus DS; Sembrat J; Rojas M; Goncharov DA; Goncharova EA; Pagano PJ
    Clin Sci (Lond); 2017 Aug; 131(15):2019-2035. PubMed ID: 28522681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Characterization of Endothelial Enhancers Reveals a Multifunctional Role for NR2F2 in Regulation of Arteriovenous Gene Expression.
    Sissaoui S; Yu J; Yan A; Li R; Yukselen O; Kucukural A; Zhu LJ; Lawson ND
    Circ Res; 2020 Mar; 126(7):875-888. PubMed ID: 32065070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.